Have invested all I can - only shortbread in my cookie jar until time into the future when I sell some but retain a good portion for ongoing dividends and future growth if we remain as a company not taken over. Genuinely though the more research partnerships that are done in addition to those arrangements done over the years, the more insulated we become. I know I have commented previously on this, but I suspect that the tantaliser for these world leading researchers is working with fellow colleagues they trust and I suspect that the research deals will have devil in detail of say change in control protections. Management of IMU and it’s partners will point to that as damaging value if a takeover is attempted. Just a commercial view having worked on protections historically. It won’t devalue it but we will see deals done for particular treatments I believe. I see it as treatment based with world licensing to keep it clean. But that is to unfold as the trials continue in earnest. GLTAH.
- Forums
- ASX - By Stock
- Rubbing my ball
Have invested all I can - only shortbread in my cookie jar until...
-
-
- There are more pages in this discussion • 785 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $418.9M |
Open | High | Low | Value | Volume |
6.0¢ | 6.2¢ | 5.6¢ | $1.863M | 31.44M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 214965 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 60000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 214965 | 0.057 |
14 | 1550875 | 0.056 |
26 | 4138021 | 0.055 |
9 | 1730287 | 0.054 |
4 | 131036 | 0.053 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 60000 | 1 |
0.059 | 708216 | 4 |
0.060 | 1196314 | 8 |
0.061 | 471000 | 3 |
0.062 | 236412 | 6 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online